Clinical trial
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk…
NCT00001496 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001496 |
|---|---|
| Title | Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer |
| Official title | Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Neoplasm, Hereditary Neoplastic Syndrome |
| Enrollment | 50 |
| Start date | Jan 1, 1996 |
| Completion | Nov 1, 2001 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: